283
Views
6
CrossRef citations to date
0
Altmetric
Research Article

A prodrug approach to enhance azelaic acid percutaneous availability

, , , &
Pages 578-586 | Received 02 Jan 2016, Accepted 13 May 2016, Published online: 27 Jun 2016

References

  • Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009;18:821–832.
  • Bhambri S, Del Rosso JQ, Bhambri A. Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol 2009;8:615–618.
  • Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 2003;83:241–248.
  • Barbareschi M, Hendricks I, Angius A, et al. The anticomedonic activity of azelaic acid investigated by means of scanning electron microscopy on horny layer biopsy. J Dermatol Treat 1991;2:55–57.
  • Gollnick H. Azelaic acid-pharmacology, toxicology and mechanisms of action on keratinization in vitro and in vivo. J Dermatol Treat 1993;4:S3–S7.
  • Nguyen QH, Bui TP. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol 1995;34:75–84.
  • Frampton JE, Wagstaff AJ. Azelaic acid 15% gel: in the treatment of Papulopustular rosacea. Am J Clin Dermatol 2004;5:57–64.
  • Liu RH, Smith MK, Basta SA, Farmer ER. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol 2006;142:1047–1052.
  • Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003;48:836–845.
  • Lowe NJ, Rizk D, Grimes P, et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Therap 1998;20:945–959.
  • Mayer-da SA, Gollnick H, Imcke E, Orfanos CE. Azelaic acid vs. placebo: effects on normal human keratinocytes and melanocytes. Electron microscopic evaluation after long-term application in vivo. Acta Derm Venereol 1986;67:116–122.
  • Mayer-da-Silva A, Gollnick H, Detmar M, et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study. Acta Derm Venereol Suppl 1989;143:20–30.
  • Gasco MR, Gallarate M, Pattarino F. In vitro permeation of azelaic acid from viscosized microemulsions. Int J Pharm 1991;69:193–196.
  • Grampurohit N, Ravikumar P, Mallya R. Microemulsions for topical use – a review. Ind J Pharm Edu Res 2011;45:100–107.
  • Manosroi J, Apriyani MG, Foe K, Manosroi A. Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. Int J Pharm 2005;293:235–240.
  • Esposito E, Menegatti E, Cortesi R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosm Sci 2004;55:253–264.
  • Reis CP, Gomes A, Rijo P, et al. Development and evaluation of a novel topical treatment for acne with azelaic acid-loaded nanoparticles. Microsc Microanal 2013;19:1141–1150.
  • Sloan KB. Prodrugs for dermal delivery. Adv Drug Deliv Rev 1989;3:67–101.
  • Johansen M, Møllgaard B, Wotton PK, et al. In vitro evaluation of dermal prodrug delivery—transport and bioconversion of a series of aliphatic esters of metronidazole. Int J Pharm 1986;32:199–206.
  • Møllgaard B, Hoelgaard A, Bundgaard H. Pro-drugs as drug delivery systems XXIII. Improved dermal delivery of 5-fluorouracil through human skin via N-acyloxymethyl pro-drug derivatives. Int J Pharm 1982;12:153–162.
  • Alzweiri M, Tarawneh R, Khanfar MA. Gas chromatography/trace analysis of derivatized azelaic acid as a stability marker. J Separation Sci 2013;36:3200–3205.
  • Manosroi A, Panyosak A, Rojanasakul Y, Manosroi J. Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines. J Drug Target 2007;15:334–341.
  • Fang J, Fang C, Sung KC, Chen H. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int J Pharm 1999;191:33–42.
  • Zhang D, Wang HJ, Cui XM, Wang CX. Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery. Pharm Dev Technol 2016. [Epub ahead of print]. DOI: 10.3109/10837450.2015.1131718.
  • Khalil E, Kretsos K, Kasting GB. Glucose partition coefficient and diffusivity in the lower skin layers. Pharm Res 2006;23:1227–1234.
  • Himonides AT. A study of the enzymatic hydrolysis of fish frames using model systems. Food Nutr Sci 2011;2:575–585.
  • Mattson FH, Volpenhein RA. Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J Lipid Res 1968;9:79–84.
  • Adler AJ, Kistiakowsky GB. Kinetics of pig liver esterase catalysis. J Am Chem Soc 1962;84:695–703.
  • Bornscheuer UT. Microbial carboxyl esterases: classification, properties and application in biocatalysis. FEMS Microbiol Rev 2002;26:73–81.
  • Hsieh PW, Al-Suwayeh SA, Fang CL, et al. The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin. Eur J Pharm Biopharm 2012;81:369–378.
  • Wayne P. Performance standards for antimicrobial susceptibility testing. Standards NCfCL; 2005.
  • Al-Bakri AG, Othman G, Bustanji Y. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J Appl Microbiol 2009;107:280–286.
  • Kramer A, Below H, Bieber N, et al. Quantity of ethanol absorption after excessive hand disinfection using three commercially available hand rubs is minimal and below toxic levels for humans. BMC Infect Dis 2007;7:117.
  • Kirschner MH, Lang RA, Breuer B, et al. Transdermal resorption of an ethanol- and 2-propanol-containing skin disinfectant. Langenbecks Arch Surg 2009;394:151–157.
  • Raghunanan L, Narine SS. Influence of structure on chemical and thermal stability of aliphatic diesters. J Phys Chem B 2013;117:14754–14762.
  • Rautio J, Kumpulainen H, Heimbach T, et al. Prodrugs: design and clinical applications. Nat Rev Drug Discov 2008;7:255–270.
  • Liu KS, Sung KC, Al-Suwayeh SA, et al. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy. Eur J Pharm Biopharm 2011;78:422–431.
  • Pepper FJ. Studies on the viability of mammalian skin autografts after storage at different temperatures. Br J Plast Surg 1954;6:250–256.
  • Oshima S, Suzuki C, Yajima R, et al. The use of an artificial skin model to study transdermal absorption of drugs in inflamed skin. Biol Pharm Bull 2012;35:203–209.
  • Wasdo SC, Juntunen J, Devarajan H, Sloan KB. A correlation of flux through a silicone membrane with flux through hairless mouse skin and human skin in vitro. Int J Pharm 2009;373:62–67.
  • Hasler-Nguyen N, Shelton D, Ponard G, et al. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection. BMC Dermatol 2009;9:1–10.
  • Watkinson RM, Herkenne C, Guy RH, et al. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin. Skin Pharmacol Physiol 2009;22:15–21.
  • Horita D, Hatta I, Yoshimoto M, et al. Molecular mechanisms of action of different concentrations of ethanol in water on ordered structures of intercellular lipids and soft keratin in the stratum corneum. Biochim Biophys Acta 2015;1848:1196–1202.
  • Moss GP, Gullick DR, Cox PA, et al. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption. J Pharm Pharmacol 2006;58:167–177.
  • Bhandari KH, Newa M, Yoon SI, et al. Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters. J Pharm Pharm Sci 2007;10:278–287.
  • Sieber MA, Hegel JK. Azelaic acid: properties and mode of action. Skin Pharmacol Physiol 2014;27:9–17.
  • Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Therap Drug Carrier Syst 1992;9:305–353.
  • Anissimov YG, Roberts MS. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics. J Pharm Sci 2009;98:772–781.
  • Seif S, Hansen S. Measuring the stratum corneum reservoir: desorption kinetics from keratin. J Pharm Sci 2012;101:3718–3728.
  • Hansen S, Selzer D, Schaefer UF, Kasting GB. An extended database of keratin binding. J Pharm Sci 2011;100:1712–1726.
  • Elias PM. Structure and function of the stratum corneum permeability barrier. Drug Dev Res 1988;13:97–105.
  • Charnock C, Brudeli B, Klaveness J. Evaluation of the antibacterial efficacy of diesters of azelaic acid. Eur J Pharm Sci 2004;21:589–596.
  • Leeming JP, Holland KT, Bojar RA. The in vitro antimicrobial effect of azelaic acid. Br. J. Dermatol 1986;115:551–556.
  • Holland K, Bojar R. Antimicrobial effects of azelaic acid. J Dermatol Treat 1993;4:S8–S11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.